AllianceBernstein’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

AllianceBernstein’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,620	Closed	-$63.3K	–	3209
2023 Q4	$63.3K	Hold	15,620	–	–	﹤0.01%	3116
2023 Q3	$42K	Sell	15,620 -202,858	-93%	-$795K	﹤0.01%	3148
2023 Q2	$2.04M	Buy	218,478 +64,161	+42%	+$632K	﹤0.01%	1878
2023 Q1	$1.37M	Buy	+154,317	New	+$1.51M	﹤0.01%	2076

AllianceBernstein's THRX Position: Q1 2024 in Review

AllianceBernstein sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 15,620 shares — an estimated $63.3K sold.

AllianceBernstein first reported a position in THRX in Q1 2023 and held it in 4 quarters. The position peaked at $2.04M in Q2 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

AllianceBernstein reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
AllianceBernstein sold 15,620 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $63.3K.
AllianceBernstein first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
AllianceBernstein's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $2.04M in Q2 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on AllianceBernstein's 13F filing for Q1 2024, filed 14 May 2024.